Drug intelligence / Profile preview

6-{[(cyclohexylamino)carbonyl]amino}hexanoic acid

Development stage: Unknown
Modality: Small Molecules

Overview

6-{[(Cyclohexylamino)carbonyl]amino}hexanoic acid is a synthetic small molecule classified as a medium-chain fatty acid derivative. It acts as an experimental inhibitor of soluble epoxide hydrolase (EPHX2), an enzyme involved in the metabolism of epoxides, including those derived from arachidonic acid. By inhibiting EPHX2, this compound may modulate pathways related to inflammation and cardiovascular function. The compound has not been approved for any therapeutic use and is primarily used as a research tool in biochemical and pharmacological studies[2][3][5].

Other names: 6-(cyclohexylcarbamoylamino)hexanoic acid6-(3-cyclohexylureido)hexanoic acid4-(3-cyclohexyluriedo)-hexanoic acid

Targets

EPHX2 (Soluble epoxide hydrolase)

Beyond the preview

Go deeper on 6-{[(cyclohexylamino)carbonyl]amino}hexanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-{[(cyclohexylamino)carbonyl]amino}hexanoic acid.

Explore the full profile